OPTIONS TRADERS AND TECHNICALS POINT TO BULLISH SURGE IN AMARIN
Just because Amarin BIO is up so much don't be scared of, options traders are betting on much higher gains to come, we tend to agree as the chart is setting up extremely bullish with they Price, RSI and Momentum indicator are all approaching the apex/top of ascending triangles. A breakout could come at any time in a stock surrounded with rumour and speculation. It looks a good risk reward long.
Alerts are set for move above $22 so as to assess for long entry.
COMPANY PROFILE
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Alerts are set for move above $22 so as to assess for long entry.
COMPANY PROFILE
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.